RE:Be patient
there seems to be a lot going on for a 50 mil operation. Currently the entire company, including the VMC is valued at half the cost of a P3 trial? To me that seems unusual. They have leap frogged through the P3 requirement with a full approval application, have reasonable cash on hand and have just announced an Orphan Drug submission with the FDA. Is there a chance that some one or some group would like to buy Bioniche for pennies on the dollar before a fraction of its current value can be realized?